慢性乙型肝炎患者二维剪切波肝脏弹性成像定量和外周血ALP/PLT比值的变化研究*

doi:10.3969/j.issn.1672-5069.2024.01.007

摘要/Abstract

摘要： 目的探讨慢性乙型肝炎(CHB)患者二维剪切波弹性成像(SWE)定量和外周血碱性磷酸酶(ALP)/血小板(PLT)比值变化及其与肝纤维化程度的关系。方法 2019年5月～2022年5月内蒙古自治区人民医院诊治的CHB患者120例,均接受肝活检病理学检查,使用超声检测肝脏杨氏模量值,常规检测血清ALP水平和全血PLT计数。采用Spearman相关性分析法分析ALP/PLT比值和杨氏模量值与肝纤维化程度的相关性。结果在120例CHB患者中,经肝组织病理学检查,发现F0/F1期38例(31.7%),F2期32例(26.7%),F3期32例(26.7%)和F4期18例(15.0%);F4期CHB患者血清ALP、外周血PLT计数、ALP/PLT比值和杨氏模量值分别为(197.1±39.7)U/L、(114.2±35.1)×10⁹/L、(1.7±0.3)和(11.7±1.7)kPa,显著不同于F3期【分别为(180.9±43.8)U/L、(137.1±38.6)×10⁹/L、(1.3±0.4)和(8.6±1.5)kPa,P均＜0.05】或F2期【分别为(162.7±41.1)U/L、(154.6±39.8)×10⁹/L、(0.9±0.2)和(6.4±1.0)kPa,P均＜0.05】或F0/F1期【分别为(150.5±36.4)U/L、(181.7±37.2)×10⁹/L、(0.7±0.2)和(5.3±1.1)kPa,P均＜0.05】;经Spearman相关性分析显示,杨氏模量值和ALP/PLT比值与肝纤维化分期均呈显著性正相关(r=0.79,P＜0.05;r=0.75,P＜0.05)。结论 CHB患者肝脏超声杨氏模量值和ALP/PLT比值水平均与肝纤维化分期呈显著性正相关,或对诊断肝纤维化分期有帮助,值得进一步研究。

关键词: 慢性乙型肝炎, 肝纤维化, 剪切波弹性成像, 杨氏模量值, 碱性磷酸酶/血小板计数比值

Abstract: Objective The aim of this study was to explore the correlation of liver Young's modulus by two-dimensional shear wave elastography (SWE) and alkaline phosphatase (ALP)/platelet (PLT) ratio to liver fibrosis in patients with chronic hepatitis B (CHB). Methods 120 patients with CHB were admitted to the Provincial People's Hospital, Inner Mongolia Autonomous Region between May 2019 and May 2022, and all patients underwent liver biopsy. The liver Young's modulus was obtained by ultrasonography, and serum ALP and whole blood PLT counts were detected routinely. The correlation of ALP / PLT ratio and Young's modulus to liver fibrosis was determined by Spearman correlation analysis. Results Out of the 120 patients with CHB, the liver histopathological examination showed F0/F1 stage in 38 cases(31.7%), F2 stage in 32 cases(26.7%), F3 stage in 32 cases(26.7%) and F4 stage in 18 cases (15.0%); serum ALP, blood PLT counts, ALP/PLT ratio and Young's modulus in patients with F4 were (197.1±39.7)U/L, (114.2±35.1)×10⁹/L, (1.7±0.3) and (11.7±1.7)kPa, all significantly different compared to [(180.9±43.8)U/L, (137.1±38.6)×10⁹/L, (1.3±0.4) and (8.6±1.5) kPa, respectively, all P＜0.05] in patients with F3 or [(162.7±41.1)U/L,(154.6±39.8)×10⁹/L,(0.9±0.2) and (6.4±1.0)kPa, respectively, all P＜0.05] in patients with F2 or [(150.5±36.4)U/L, (181.7±37.2)×10⁹/L, (0.7±0.2) and (5.3±1.1)kPa, respectively, all P＜0.05] in patients with F0/F1; the Spearman analysis showed that the Young's modulus and ALP/PLT ration in patients with CHB were positively correlated to liver fibrosis staging (r=0.79, P＜0.05; r=0.75, P＜0.05). Conclusion The Young's modulus and ALP / PLT ratio in patients with CHB are correlated to liver fibrosis, which might help predict the liver fibrosis staging and warrants further clinical investigation.

Key words: Hepatitis B, Liver fibrosis, Shear wave elastography, Young's modulus, Alkaline phosphatase to platelet ratio

武雯雯, 仇艳坤. 慢性乙型肝炎患者二维剪切波肝脏弹性成像定量和外周血ALP/PLT比值的变化研究^*[J]. 实用肝脏病杂志, 2024, 27(1): 24-27.

Wu Wenwen, Qiu Yankun. Correlation of liver Young's modulus by two-dimensional shear wave elastography and ALP/PLT ratio to liver fibrosis in patients with chronic hepatitis B[J]. Journal of Practical Hepatology, 2024, 27(1): 24-27.

参考文献

[1] Khomich O, Ivanov A V, Bartosch B. Metabolic hallmarks of hepatic stellate sells in liver fibrosis. Cells,2019,9(1):24-29.
[2] Pantano L, Agyapong G, Shen Y, et al. Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD. Sci Rep,2021,11(1):18045.
[3] Gheorghe G, Bungau S, Ceobanu G, et al. The non-invasive assessment of hepatic fibrosis. J Formos Med Assoc,2021,120(2):794-803.
[4] 德吉,白玛,白央,等. CHB和肝硬化患者肝脏硬度检测值的变化及其影响因素分析. 实用肝脏病杂志,2019,22(3):401-404.
[5] 李曼,张军,李涛,等. ADA/PLT、ALP/PLT比值比值对肝纤维化的诊断价值. 中国实验诊断学,2017,21(11):1923-1926.
[6] 中国中西医结合学会肝病专业委员会. 肝纤维化中西医结合诊疗指南(2019年版). 中华肝脏病杂志,2019,27(7):494-504.
[7] 江超,郭鲁,时丹丹,等. 二维剪切波弹性成像检测乳腺癌术后化疗患者肝弹性值变化的应用价值. 中华超声影像学杂志,2022,31(4):312-317.
[8] Borro P, Ziola S, Pasta A, et al. Hepatic elastometry and glissonian Line in the assessment of liver fibrosis. Ultrasound Med Biol,2021,47(4):947-959.
[9] Fuentes-Velez S, Fagoonee S, Sanginario A, et al. Electrical impedance-based characterization of hepatic tissue with early-stage fibrosis. Biosensors (Basel),2022,12(2):116-119.
[10] Jin K, Wang H, Zeng M, et al. A comparative study of MR extracellular volume fraction measurement and two-dimensional shear-wave elastography in assessment of liver fibrosis with chronic hepatitis B. Abdom Radiol (NY),2019,44(4):1407-1414.
[11] Chin J, Powell L W, Ramm L E, et al. Utility of serum biomarker indices for staging of hepatic fibrosis before and after venesection in patients with hemochromatosis caused by variants in HFE. Clin Gastroenterol Hepatol,2021,19(7):1459-1468.
[12] Albillos A, Martin-Mateos R, Van der Merwe S, et al. Cirrhosis-associated immune dysfunction. Nat Rev Gastroenterol Hepatol,2022,19(2):112-134.
[13] Kim M N, Lee J H, Chon Y E, et al. Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsy. Eur J Gastroenterol Hepatol,2020,32(3):433-439.
[14] Dong B, Lyu G, Chen Y, et al. Comparison of two-dimensional shear wave elastography, magnetic resonance elastography, and three serum markers for diagnosing fibrosis in patients with chronic hepatitis b: a meta-analysis. Expert Rev Gastroenterol Hepatol,2021,15(9):1077-1089.
[15] Baldea V, Sporea I, Tudor A, et al. Virtual touch quantification using acoustic radiation force impulse imaging technology versus transient elastography for the noninvasive assessment of liver fibrosis in patients with chronic hepatitis B or C using liver biopsy as the gold standard. J Gastrointestin Liver Dis,2020,29(2):181-190.
[16] 杨艳秋,程颢,冯敏. 肝脏剪切波弹性成像对CHB患者肝纤维化的评估价值. 实用肝脏病杂志,2021,24(4):480-483.
[17] Nabavizadeh A, Payen T, Iuga AC, et al. Noninvasive Young's modulus visualization of fibrosis progression and delineation of pancreatic ductal adenocarcinoma (PDAC) tumors using harmonic motion elastography (HME) in vivo. Theranostics,2020,10(10):4616-4626.
[18] Gatselis NK, Goet JC, Zachou K, et al. Factors associated with progression and outcomes of early stage primary biliary cholangitis. Clin Gastroenterol Hepatol,2020,18(3):684-692.
[19] Gold L C, Macpherson I, Nobes J H, et al. Thrombocytosis and abnormal liver enzymes: a trigger for investigation of underlying malignancy. PLoS One,2022,17(4):267-274.
[20] Dong B, Huang S, Chang J, et al. Comparison of sound touch elastography, sound touch quantify, and 4 serum fibrosis indexes for the diagnosis of liver fibrosis in patients with chronic hepatitis B. Ultrasound Q,2021,37(2):123-128.
[21] Cheng M Q, Hu H T, Huang H, et al. Pathological considerations of CEUS LI-RADS: correlation with fibrosis stage and tumour histological grade. Eur Radiol,2021,31(8):5680-5688.
[22] 翟相威,刘树红,姚明解,等. 基于血清高尔基体蛋白73的代偿期乙型肝炎肝硬化无创诊断模型的建立及初步应用. 中华肝脏病杂志,2020,28(1):47-52.
[23] Nielsen MJ, Leeming DJ, Goodman Z, et al. Comparison of ADAPT, FIB-4 and APRI as non-invasive predictors of liver fibrosis and NASH within the CENTAUR screening population. J Hepatol,2021,75(6):1292-1300.
[24] Pan Y, Yang K, Sun B, et al. Application of alkaline phosphatasetoplatelet ratio as a novel noninvasive index predicts liver fibrosis in patients with chronic hepatitis B. Exp Ther Med,2022,24(4):619-692.
[25] Pyo JY, Ahn SS, Lee LE, et al. The novel fibrosis index at diagnosis may predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis without substantial liver diseases. Clinics (Sao Paulo),2021,76(1):2501.

慢性乙型肝炎患者二维剪切波肝脏弹性成像定量和外周血ALP/PLT比值的变化研究^*

Correlation of liver Young's modulus by two-dimensional shear wave elastography and ALP/PLT ratio to liver fibrosis in patients with chronic hepatitis B

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	虞珊珊, 张业婷, 王元鹏, 袁静文, 肖立. 慢性乙型肝炎患者血清MMP-1、MMP-2、TIMP-1和HIF-1α变化及其临床意义探讨^*[J]. 实用肝脏病杂志, 2024, 27(3): 329-332.
[2]	罗良德, 任成果, 王守军, 邓颖春. 恩替卡韦联合多烯磷脂酰胆碱治疗慢性乙型肝炎合并NASH患者疗效研究^*[J]. 实用肝脏病杂志, 2024, 27(3): 333-336.
[3]	周安琪, 孟舒婷, 吴应冬, 张弦. 接受核苷(酸)类似物抗病毒的慢性乙型肝炎患者发生低病毒血症危险因素分析^*[J]. 实用肝脏病杂志, 2024, 27(3): 337-340.
[4]	尹丹丹, 张瑞珏, 王帅, 代爱军, 周正, 张帆. 30岁以下血清ALT正常的成人慢性HBV感染者肝组织学变化研究[J]. 实用肝脏病杂志, 2024, 27(3): 341-344.
[5]	彭玉静, 郭航, 陈俊光. 应用超声评分联合STE/STQ定量检测肝脏硬度评估慢性乙型肝炎患者肝纤维化程度价值研究^*[J]. 实用肝脏病杂志, 2024, 27(3): 345-348.
[6]	程艳洁, 王鹏飞, 李峻. 水飞蓟素联合复方蛋氨酸胆碱治疗酒精性肝炎患者疗效及其对血清肝纤维化指标的影响^*[J]. 实用肝脏病杂志, 2024, 27(3): 349-352.
[7]	蔡峻岭, 苏立, 郝丽, 赵敏, 裴旭东. 基于索磷布韦的直接抗病毒药物治疗丙型肝炎肝硬化患者疗效评价^*[J]. 实用肝脏病杂志, 2024, 27(3): 406-409.
[8]	孙超, 段晓燕, 葛文松, 范建高. 未分化结缔组织病相关肝纤维化1例报告[J]. 实用肝脏病杂志, 2024, 27(3): 470-472.
[9]	李敏, 张丽, 曾艾, 刘世裕. 2型糖尿病合并非酒精性脂肪性肝病患者肝纤维化检出率及预测因素分析^*[J]. 实用肝脏病杂志, 2024, 27(2): 193-197.
[10]	万贵香, 李忠廉, 赵亚博, 梁微微, 杜辉, 宁振海, 周媛, 万亮. 恩替卡韦联合扶正解毒散结方治疗乙型肝炎肝硬化患者疗效研究^*[J]. 实用肝脏病杂志, 2024, 27(2): 234-237.
[11]	李凯, 石波, 程序, 赵凯. 应用STE/STQ技术评估慢性乙型肝炎患者肝纤维化程度效能研究^*[J]. 实用肝脏病杂志, 2024, 27(1): 20-23.
[12]	张书琴, 王婷婷, 张艳红. 实时组织弹性成像评估非酒精性脂肪性肝炎患者肝纤维化分期临床价值研究^*[J]. 实用肝脏病杂志, 2024, 27(1): 48-51.
[13]	宋涛, 徐敏, 党子龙, 孙珺珺. 恩替卡韦联合α-干扰素治疗慢性乙型肝炎患者疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 785-788.
[14]	高丽娟, 李永库, 董新颖, 杨艺宁, 冷雪君. 艾米替诺福韦治疗慢性乙型肝炎患者疗效初步研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 789-792.
[15]	周季颖, 谢月红, 于翠霞. 恩替卡韦治疗慢性乙型肝炎合并非酒精性脂肪性肝病患者疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 793-796.